Nasdaq:US$12.13 (-0.47) | HKEX:HK$18.98 (-0.42) | AIM:£2.00 (+0)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases | 16 Apr 2023

AACR 2023: Preclinical characteristic of HMPL-306, a CNS-penetrable dual inhibitor of mutant IDH1 and IDH2